<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0010998'>Pulmonary alveolar proteinosis</z:mp> (<z:mp ids='MP_0010998'>PAP</z:mp>) is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> characterized by the abnormal accumulation of alveolar <z:chebi fb="4" ids="35195">surfactant</z:chebi> protein in alveolar spaces </plain></SENT>
<SENT sid="1" pm="."><plain>We report herein a rare case of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) complicated by severe <z:mp ids='MP_0010998'>PAP</z:mp>, and successful allogeneic bone marrow transplantation (BMT) for both disorders </plain></SENT>
<SENT sid="2" pm="."><plain>An unrelated BMT was planned for a 48-year-old male with advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Just before the initiation of the conditioning regimen for unrelated BMT in March 2007, he developed <z:hpo ids='HP_0002094'>dyspnea</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A diagnosis of <z:mp ids='MP_0010998'>PAP</z:mp> was made based on findings of chest X-ray, CT scanning, and the fluid obtained by bronchoalveolar lavage </plain></SENT>
<SENT sid="5" pm="."><plain>To improve his <z:hpo ids='HP_0002094'>dyspnea</z:hpo> and improve BMT safety, whole lung lavage (WLL) was performed twice, with the partial improvement of <z:mp ids='MP_0010998'>PAP</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Unrelated allogeneic BMT was performed in September 2007 </plain></SENT>
<SENT sid="7" pm="."><plain>We had to perform a third WLL because of the worsening of <z:mp ids='MP_0010998'>PAP</z:mp> on day 26 after BMT </plain></SENT>
<SENT sid="8" pm="."><plain>Despite many infectious complications after BMT, GVHD was relatively mild </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0010998'>PAP</z:mp> had almost disappeared 6 months after BMT </plain></SENT>
<SENT sid="10" pm="."><plain>He was well with favorable hematopoiesis 20 months after the BMT without any specific treatment </plain></SENT>
<SENT sid="11" pm="."><plain>There has been no report of an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient with <z:mp ids='MP_0010998'>PAP</z:mp> in whom 3 WLL procedures were performed before and after allogeneic BMT </plain></SENT>
</text></document>